By Sam Baker
The scientific race for a coronavirus vaccine is moving at record-shattering speed. Making the most of that work — translating a successful clinical product into real-world progress — will require some patience.
Why it matters: If we get a vaccine relatively soon, the next big challenge will be balancing the need to get it into people's hands with the need to keep working on other solutions that might prove more effective.
Where it stands: Eight potential vaccines are in late-stage clinical trials. The first one could be submitted for FDA review as early as October or November, and several more could follow within just a few months. Read more >>